# HK inno.N

> HK inno.N is a VC fund in Seoul backing Health Care and Biotechnology. See 5 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 5
- Last investment: Apr 2024
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/cjhealthcare/?originalSubdomain=in
- Website: http://www.inno-n.com/eng/

HK inno.N is a VC fund in Seoul focused on Health Care and Biotechnology. CJ HealthCare Corp. develops pharmaceutical vaccines.

## Contacts

5 contacts available for HK inno.N. Shizune tracks 2 team members at HK inno.N. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cj-healthcare-corp?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Biotechnology | 2 | 40% |
| Manufacturing | 2 | 40% |
| Pharmaceutical | 2 | 40% |
| Medical | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 20% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |
| Corporate Round | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Seokhee Kang | CEO | 0 | https://shizune.co/investors/profile/seokhee-kang |
| Yoonhee Kim | Senior Analyst, Business Development | 0 | https://shizune.co/investors/profile/yoonhee-kim |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Protium Science | Protium Science is a drug research and development company that provides analytical and quality assurance services. | $1.5M | Corporate Round | Apr 04, 2024 | http://protiumscience.com |
| Oncobix | Oncobix is an operator of a drug development company that develops innovative treatments for rare and incurable diseases that are challenging to treat with modern medicine. For the well-being of humanity, the company invented a novel compound that can be represented by a chemical formula or a salt thereof, along with a pharmaceutical compositioncontaining the compound, so that patients can enjoy innovative new drugs. | $2.8M | Series B | Sep 23, 2022 | http://oncobix.com  |
| Y-Biologics | Y-Biologics is specialized in antibody drug since its inception has focused on research and development. They have successfully constructed the unique human antibody library Y-max ABL and new dual antibody platform technology ALiCE. Based on this, they have developed various antibody drugs and become a leading company in the globalimmuno-chemotherapeutic drug market They are doing their best to leap forward. | $24.9M | Venture - Series Unknown | Feb 24, 2022 | http://ybiologics.com/ |
| AIO Foods | AIO Foods is a food-tech startup that designs and manufactures personalized food. |  | Seed | Aug 27, 2021 | https://aiofoods.io |
| Next&Bio | Next&Bio is a company that provides researchers and consumers with a new concept of medicine and pharmacy based on original technology. | $5.3M | Series A | Apr 03, 2020 | http://nextandbio.com/ |

5 of 5 investments shown.

## Co-investors
- [Base Investments](https://shizune.co/investors/profile/base-investments) — VC Fund, 1 deal together
- [Bass Investment](https://shizune.co/investors/profile/bass-investment) — VC Fund, 1 deal together
- [Dayli Partners](https://shizune.co/investors/profile/dayli-partners) — VC Fund, 1 deal together
- [DS Asset Management](https://shizune.co/investors/profile/ds-asset-management) — VC Fund, 1 deal together
- [Genexine](https://shizune.co/investors/profile/genexine) — VC Fund, 1 deal together
- [Hyundai Investment Partners](https://shizune.co/investors/profile/hyundai-investment-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Climate Investors in South Korea](https://shizune.co/investors/climate-investors-south-korea)
- [Climate VC Funds in South Korea](https://shizune.co/investors/climate-vc-funds-south-korea)
- [Manufacturing Investors in South Korea](https://shizune.co/investors/manufacturing-investors-south-korea)
- [Manufacturing VC Funds in South Korea](https://shizune.co/investors/manufacturing-vc-funds-south-korea)
- [Gaming VC Funds in South Korea](https://shizune.co/investors/gaming-vc-funds-south-korea)
- [Medical Device Investors in South Korea](https://shizune.co/investors/medical-device-investors-south-korea)

## FAQ

### What does HK inno.N invest in?

HK inno.N invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact HK inno.N?

Public channels for HK inno.N include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at HK inno.N?

The team at HK inno.N includes Seokhee Kang (CEO) and Yoonhee Kim (Senior Analyst, Business Development). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co